Dissecting the role of TP53 alterations in del(11q) chronic lymphocytic leukemia-Reference-Cited by-同舟云学术

Dissecting the role of TP53 alterations in del(11q) chronic lymphocytic leukemia

Published:2021-02 Issue:2 Volume:11 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical and Translational Medicine

Author:

Quijada‐Álamo Miguel¹²,Pérez‐Carretero Claudia¹²,Hernández‐Sánchez María¹²³⁴,Rodríguez‐Vicente Ana‐Eugenia¹²,Herrero Ana‐Belén¹²,Hernández‐Sánchez Jesús‐María¹²,Martín‐Izquierdo Marta¹²,Santos‐Mínguez Sandra¹²,del Rey Mónica¹²,González Teresa²,Rubio‐Martínez Araceli⁵,García de Coca Alfonso⁶,Dávila‐Valls Julio⁷,Hernández‐Rivas José‐Ángel⁸,Parker Helen⁹,Strefford Jonathan C.⁹,Benito Rocío¹²,Ordóñez José‐Luis¹²,Hernández‐Rivas Jesús‐María¹²¹⁰^ORCID

Affiliation:

1. Cancer Research Center University of Salamanca, IBSAL, IBMCC, CSIC Salamanca Spain

2. Department of Hematology University Hospital of Salamanca Salamanca Spain

3. Department of Medical Oncology Dana‐Farber Cancer Institute Boston Massachusetts USA

4. Broad Institute of Harvard and MIT Cambridge Massachusetts USA

5. Department of Hematology Hospital Miguel Servet Zaragoza Spain

6. Department of Hematology Hospital Clínico de Valladolid Valladolid Spain

7. Department of Hematology Hospital Nuestra Señora de Sonsoles Ávila Spain

8. Department of Hematology Hospital Universitario Infanta Leonor, Universidad Complutense Madrid Spain

9. School of Cancer Sciences Faculty of Medicine University of Southampton Southampton UK

10. Department of Medicine University of Salamanca Salamanca Spain

Publisher